PRESS RELEASE published on 05/15/2024 at 22:05, 2 years 1 month ago SWK Holdings Corporation Announces Financial Results for First Quarter 2024 SWK Holdings Corporation announces first quarter 2024 financial and operating results, with $11.8 million total revenue and $0.9 million GAAP net income. Join the conference call on May 16, 2024, at 10:00 a.m. ET for more details Financial Results Conference Call SWK Holdings Corporation First Quarter 2024 Finance Segment
BRIEF published on 03/21/2024 at 12:05, 2 years 3 months ago SWK Holdings Corporation annonce des résultats financiers positifs pour le quatrième trimestre 2023 Résultats Financiers T4 2023 Financement Spécialisé SWK Holdings Financement Des Sciences De La Vie
BRIEF published on 03/21/2024 at 12:05, 2 years 3 months ago SWK Holdings Corporation Reports Positive Financial Results for Q4 2023 Financial Results Life Science Finance Q4 2023 Specialty Finance SWK Holdings
PRESS RELEASE published on 03/21/2024 at 12:00, 2 years 3 months ago SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2023 SWK Holdings Corporation announces business update and financial results for Q4 2023, showcasing $2.8 million net income. Includes details on senior notes offering, share repurchases, and Exclusive Option and Asset Purchase Agreement Financial Results Net Income SWK Holdings Corporation Senior Notes Offering Exclusive Option And Asset Purchase Agreement
PRESS RELEASE published on 01/23/2024 at 22:05, 2 years 5 months ago SWK Holdings Highlights Recent Achievements and Provides Portfolio Update SWK Holdings Corporation provided a corporate progress update and summarized the achievements of its borrower partners, closing approximately $60 million of financings with $55 million deployed in the fourth quarter of 2023. The portfolio of life science finance receivables grew to an all-time high as of December 31, 2023, positioning the company for sustained growth and positive returns to shareholders through selective investment in innovative life science companies. SWK Holdings Corporation Life Science Finance Small And Mid-sized Companies Corporate Progress Portfolio Updates
Published on 06/26/2026 at 01:40, 11 hours 10 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 20 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 20 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 15 hours 18 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/26/2026 at 12:18, 32 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 20 minutes ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 1 hour 35 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 1 hour 45 minutes ago Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 07:00, 5 hours 50 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 5 hours 50 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 5 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 20 minutes ago Avis financier semestriel SIEHM au 30 avril 2026